Isidakamizwa se-Cancer sineqhwa kodwa impande engavamile
Umcabango wokuthi ungenayo iminwe yeminwe ingase yamukelwe ngumuntu okhubazekile, kodwa ngoJoe isilinganiso, umcabango uyakhubaza. Vele ubuze indoda yaseSingapore eyazama ukungena e-US futhi igcinwe ngoba yayingenayo iminwe yeminwe. Umlandu? I-Capecitabine.
I-Hand-Foot Syndrome ene-Capecitabine (Xeloda)
Ukulahleka kwamafingerprint kuyinto engavamile uma uthatha i-capecitabine yezidakamizwa, eyaziwa nangokuthi i-Xeloda ngegama layo lebhizinisi.
Isizathu sokulahlekelwa kweminwe kuhlobene nomphumela ohlangothini wesidakamizwa esibizwa ngokuthi i- hand-foot syndrome (i-HFS), okubangela ukubomvu, ukulinganisa, nokomile kwezandla nezinyawo. Lemiphumela emibi ingathuthuka ibe izimpawu ezingathí sina, njengokuhlanjululwa nokuhlunga kwezandla nezinyawo ezinyaweni. Eminye imithi yomdlavuza ingabangela i-HFS, kodwa kwenzeka kaningi kubantu abaphatha i-capecitabine.
Ukuvimbela kanye nokungenelela kokuqala kwezokwelapha kuyisihluthulelo uma kuziwa kwi-HFS. Ngokuvamile, umuntu uzothola ukuphazamiseka nokumboza ezandleni nasezinyaweni ngaphambi kokuqala ukuqala, ngakho kubaluleke kakhulu ukwazisa udokotela wakho ngokushesha lokhu kwenzeka. Uma kushiywe kungalashwa, izinkinga ezingathí sina zingakhula, njengokubheka nokubunjwa kwe-blisters nezilonda ezintendeni nasezintweni zezandla nezinyawo. Imiphumela ye-HFS ingaphazamisa kakhulu imisebenzi yansuku zonke efana nokuhamba nokuqoqa izinto.
Ukulahleka kwamafingerprint kuyinto engavamile ngokuthatha umuthi.
Kukholelwa ukuthi ubude besikhathi lapho umuthi uthathwa khona nokuthi kuthatha isikhathi eside kangakanani umzimba ukuba usebenze ngokubambisana nawo izici ezibalulekile ekuthuthukiseni imiphumela emibi engavamile njengokulahlekelwa kweminwe. Kunconywa ukuthi uma uthatha i-capecitabine futhi uhambo oluya kumazwe adinga ukukhonjwa kweminwe yezinhlamvu zokungena kwakho ophethe incwadi evela ku-oncologist yakho eveza ukwelashwa kwakho kwe-capecitabine nemiphumela yayo emibi.
Kubalulekile ukuqaphela ukuthi iningi labantu abathatha imithi yomdlavuza ehlotshaniswa ne-HFS abahlali namacala amakhulu. I-HFS enhle ingaba yinto evamile, ikakhulukazi nge-capecitabine, kodwa kubantu abaningi, ayike ikhule ngaphezu kwalokho.
Eminye imiphumela emibi
Uma unengqondo yobugebengu, i-capecitabine akufanele ibe yisinqumo sakho sokuqala sokumboza ubugebengu bakho. Umphumela wecala ovamile yisifo sohudo, okungenza kube nzima ukuhlela nokwenza i-caper yakho. Linciphisa ikhono lakho lokulwa nokutheleleka futhi unciphisa amaplatelet akha amaqabunga egazini lakho. Futhi ingakwazi ukuxhumana nama-anticoagulants futhi ukwandise ingozi yokuphuma kwegazi, inexwayiso ebhokisini elibomvu kulokhu kusebenzisana njengoba kungabulala. Ukushiya umzila wegazi endaweni yesehlakalo sakho ububi njengokushiya iminwe yeminwe.
> Umthombo:
> "Capecitabine," i-MedlinePlus, i-US National Library of Medicine, i-NIH. 10/15/2011.